The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Pure Red Cell Aplasia: Diagnostic and Treatment Strategy

Selective erythroid lineage failure with diverse etiologies and targeted immunosuppressive therapy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Pure Red Cell Aplasia: Diagnostic and Treatment Strategy?

Pure red cell aplasia is defined by severe normochromic normocytic anemia with reticulocyte count below 1 percent and erythroid precursors below 0.5 percent in marrow.

Acquired forms include idiopathic, immune-mediated, drug-induced, parvovirus B19 infection, thymoma-associated and chronic lymphocytic leukemia-associated.

Congenital form (Diamond-Blackfan anemia) presents in infancy with characteristic genetic mutations affecting ribosomal proteins.

Diagnostic workup includes parvovirus B19 PCR, antibody testing, lymphocyte phenotyping, thymus imaging and bone marrow examination.

Differential diagnosis includes aplastic anemia, myelodysplastic syndrome and other selective cytopenias.

Symptoms

Progressive fatigue, weakness and decreased exercise tolerance from severe anemia.
Pallor of skin and mucous membranes with conjunctival pallor.
Cardiac symptoms including palpitations, dyspnea on exertion and high-output heart failure in severe cases.
Symptoms of underlying cause including thymoma-related compression or chronic lymphocytic leukemia-related lymphadenopathy.
Recurrent transfusion requirement leading to iron overload over time.

Risk Factors

Underlying autoimmune disease or thymoma diagnosis.
Chronic lymphocytic leukemia or large granular lymphocytic leukemia.
Recent parvovirus B19 infection particularly in immunocompromised hosts.
Use of medications associated with PRCA including erythropoietin (anti-erythropoietin antibodies), phenytoin, mycophenolate.
Solid organ or hematopoietic stem cell transplantation with ABO incompatibility.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Severe normochromic normocytic anemia with reticulocytopenia warrants comprehensive hematologic evaluation.
  • Persistent transfusion-dependent anemia without explanation requires bone marrow examination and underlying cause workup.
  • Newly diagnosed thymoma with anemia or chronic lymphocytic leukemia with worsening anemia needs PRCA evaluation.
  • Unexplained severe anemia in immunocompromised host should prompt parvovirus B19 testing.
  • Long-term surveillance with periodic monitoring is essential given relapse potential and emergence of underlying conditions.

Treatment Methods

01
Treatment of underlying cause when identifiable including thymectomy for thymoma, treatment of CLL or discontinuation of offending drug.
02
Immunosuppressive therapy with cyclosporine A is first-line for idiopathic and immune-mediated PRCA.
03
Intravenous immunoglobulin for parvovirus B19-associated PRCA particularly in immunocompromised patients.
04
Second-line options include rituximab, alemtuzumab, anti-thymocyte globulin and cyclophosphamide for refractory disease.
05
Comprehensive supportive care with red cell transfusions, iron chelation for transfusion-related iron overload, monitoring for treatment-related complications and lifelong surveillance optimize outcomes in this rare condition.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.